Clinical trial
Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Name
UCSF Infectious Diseases
Description
Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).
Trial arms
Treatment
sodium stibogluconate (Pentostam)
20 mg/kg IV every day for 20 or 28 days
Size
-1
Eligibility criteria
Inclusion Criteria:
* Biopsy proven new world cutaneous or mucocutaneous leishmania
Exclusion Criteria:
* Prolonged QT
* Liver disease
* Pancreatitis
Protocol
{'studyType': 'EXPANDED_ACCESS'}
Updated at
2023-12-27
1 organization
1 product
3 indications
Organization
University of California, San FranciscoProduct
Sodium stibogluconateIndication
LeishmaniasisIndication
CutaneousIndication
Mucocutaneous